June 27, 2023 Comments Off on New patent for Boehringer Ingelheim drug JARDIANCE Posted in: Patent Added Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from five suppliers. There are seven patents…
The post New patent for Boehringer Ingelheim drug JARDIANCE appe…
June 27, 2023 Comments Off on New patent for Boehringer Ingelheim drug JENTADUETO Posted in: Patent Added Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are twelve patents…
The post New patent for Boehringer Ingelheim drug JENTADUETO a…
